Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy 22nd Century Group IncCommon Stock stock in Canada

Own 22nd Century Group IncCommon Stock shares in just a few minutes.

22nd Century Group IncCommon Stock is a drug manufacturers-specialty & generic business based in the US. 22nd Century Group IncCommon Stock stocks (XXII.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.52 – a decrease of 16.6% over the previous week. 22nd Century Group IncCommon Stock employs 67 staff and has a trailing 12-month revenue of around $30.3 million.

How to buy shares in 22nd Century Group IncCommon Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – XXII – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

22nd Century Group IncCommon Stock stock price (NASDAQ:XXII)

Use our graph to track the performance of XXII stocks over time.

22nd Century Group IncCommon Stock shares at a glance

Information last updated 2022-01-17.
Latest market close$2.06
52-week range$1.86 - $6.07
50-day moving average $2.70
200-day moving average $3.47
Wall St. target price$6.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.17

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy 22nd Century Group IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

22nd Century Group IncCommon Stock price performance over time

Historical closes compared with the close of $2.06 from 2022-01-21

1 week (2022-01-14) -16.60%
1 month (2021-12-20) N/A
3 months (2021-10-20) N/A
6 months (2021-07-23) -34.81%
1 year (2021-01-22) -26.16%
2 years (2020-01-23) 92.52%
3 years (2019-01-23) 2.18
5 years (2017-01-23) 125.14%

22nd Century Group IncCommon Stock financials

Revenue TTM $30.3 million
Gross profit TTM $1.4 million
Return on assets TTM -21.98%
Return on equity TTM -38.82%
Profit margin -82.68%
Book value $0.49
Market capitalisation $402 million

TTM: trailing 12 months

22nd Century Group IncCommon Stock share dividends

We're not expecting 22nd Century Group IncCommon Stock to pay a dividend over the next 12 months.

Have 22nd Century Group IncCommon Stock's shares ever split?

22nd Century Group IncCommon Stock's shares were split on a 1391:500 basis on 30 November 2010. So if you had owned 500 shares the day before before the split, the next day you'd have owned 1391 shares. This wouldn't directly have changed the overall worth of your 22nd Century Group IncCommon Stock shares – just the quantity. However, indirectly, the new 64.1% lower share price could have impacted the market appetite for 22nd Century Group IncCommon Stock shares which in turn could have impacted 22nd Century Group IncCommon Stock's share price.

22nd Century Group IncCommon Stock share price volatility

Over the last 12 months, 22nd Century Group IncCommon Stock's shares have ranged in value from as little as $1.86 up to $6.07. A popular way to gauge a stock's volatility is its "beta".

XXII.US volatility(beta: 1.92)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 22nd Century Group IncCommon Stock's is 1.9169. This would suggest that 22nd Century Group IncCommon Stock's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

22nd Century Group IncCommon Stock overview

22nd Century Group, Inc. , a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N. V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site